Showing results (1171-1180 of 3,525) with videos related to

Sort By:
Pageof 353
Thoracic Cancer|October 20, 2018
Clinical investigation of the efficacy and toxicity of apatinib (YN968D1) in stage III/IV non-small cell lung cancer after second-line chemotherapy treatment: A retrospective studyDi Zhang, Chufeng Zhang, Jiaqi Huang, et al.
Thoracic Cancer|April 4, 2017
Development of a prognosis-prediction model incorporating genetic polymorphism with pathologic stage in stage I non-small cell lung cancer: A multicenter studyWon Kee Lee, Shin Yup Lee, Jin Eun Choi, et al.
Thoracic Cancer|August 28, 2019
Diffuse large B-cell lymphoma in a patient with dermatomyositis-associated interstitial lung disease: A case reportShan Li, Yuxin Sun, Chi Shao, et al.
Thoracic Cancer|August 14, 2019
Can emphysema influence size discrepancy between radiologic and pathologic size measurement in subsolid lung adenocarcinomas?Jae-Kwang Lim, Kyung Min Shin, Sang Yub Lee, et al.
Thoracic Cancer|April 1, 2019
Extracranial abscopal effect induced by combining immunotherapy with brain radiotherapy in a patient with lung adenocarcinoma: A case report and literature reviewXinqing Lin, Tingting Lu, Zhanhong Xie, et al.
Thoracic Cancer|August 3, 2019
Short-term outcomes of typical versus atypical lung segmentectomy by minimally invasive surgeriesBoheng Xie, Xiao Sun, Yi Qin, et al.
Thoracic Cancer|August 29, 2025
Pure Red Cell Aplasia That Developed 13 Years After Thymoma Treatment: A Case Report and Literature ReviewKento Kono, Kazuhisa Nakashima, Yukari Tsubata, et al.
Thoracic Cancer|May 16, 2020
18 F-FDG PET/CT imaging of small intestinal metastasis from pulmonary sarcomatoid carcinoma: Brief report and review of the literatureXinli Xie, Ning Tu, Qi Wang, et al.
Thoracic Cancer|May 19, 2020
Switching administration of anti-PD-1 and anti-PD-L1 antibodies as immune checkpoint inhibitor rechallenge in individuals with advanced non-small cell lung cancer: Case series and literature reviewShingo Kitagawa, Taiki Hakozaki, Rui Kitadai, et al.
Thoracic Cancer|May 19, 2020
Bevacizumab plus chemotherapy in nonsquamous non-small cell lung cancer patients with malignant pleural effusion uncontrolled by tube drainage or pleurodesis: A phase II study North East Japan Study group trial NEJ013BRintaro Noro, Kunihiko Kobayashi, Jiro Usuki, et al.
Pageof 353